106 related articles for article (PubMed ID: 2355503)
1. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
Kannagi R; Itai S; Harada R
Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
[No Abstract] [Full Text] [Related]
2. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
3. [2 --> 6 sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2010 Jul; 68 Suppl 7():703-8. PubMed ID: 20960854
[No Abstract] [Full Text] [Related]
4. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
[No Abstract] [Full Text] [Related]
5. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of blood group antigen in sera as a tumor marker].
Imai K; Arimura Y; Yachi A
Nihon Rinsho; 1990 Feb; 48 Suppl():912-6. PubMed ID: 1972427
[No Abstract] [Full Text] [Related]
7. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
8. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of Lewis blood-group phenotype and serum CA-19-9 analysis in the diagnosis of diabetic diseases].
Shimojo N; Okuda K
Nihon Rinsho; 1990 Dec; 48 Suppl():359-64. PubMed ID: 2086909
[No Abstract] [Full Text] [Related]
10. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
11. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
12. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
Jovin G; Stănel I; Popovici I; Oproiu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
[No Abstract] [Full Text] [Related]
13. [2-->6 sialyl Lea antigen].
Kannagi R
Nihon Rinsho; 1999 Dec; 57 Suppl():488-94. PubMed ID: 10778171
[No Abstract] [Full Text] [Related]
14. [Clinical significance of elastase 1 assay as a tumor marker].
Kimura T; Nawata H
Nihon Rinsho; 1990 Feb; 48 Suppl():899-902. PubMed ID: 2355631
[No Abstract] [Full Text] [Related]
15. Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer.
Satoh H; Ishikawa H; Yamashita YT; Takahashi H; Ishikawa S; Kamma H; Ohtsuka M; Hasegawa S
Anticancer Res; 1998; 18(4B):2865-8. PubMed ID: 9713476
[TBL] [Abstract][Full Text] [Related]
16. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
[No Abstract] [Full Text] [Related]
17. Expression of sialyl Lex, sialyl Lea, Lex and Ley glycotopes in secreted human ovarian cyst glycoproteins.
Yang Z; Wu JH; Kuo HW; Kannagi R; Wu AM
Biochimie; 2009 Mar; 91(3):423-33. PubMed ID: 19059303
[TBL] [Abstract][Full Text] [Related]
18. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of Span-1 antigen assay as a tumor marker].
Satake K; Chung YS; Umeyama K
Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
[No Abstract] [Full Text] [Related]
20. [Sialyl Tn antigen].
Kannagi R
Nihon Rinsho; 1999 Dec; 57 Suppl():482-7. PubMed ID: 10778170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
